In this study, we did not restrict either the GLP-1 treatment cohort or the control cohort to any specific medication regimen, dosage trajectory or adjunctive interventions, as the intent was to capture the full range of possible real-world medication usage that is occurring
Whether 500 mg/day achieves pharmacologically meaningful hepatic target engagement in patients with cirrhosis, where intestinal permeability, portal hypertension, and first-pass metabolism are all altered, remains unknown and is a significant uncertainty underlying the biological interpretation of this study
Your body naturally produces less of this molecule as you age
Can I take L-Carnitine on an empty stomach
*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality
Bioverse has both name brand and generic GLP-1s